The FDA approved Vertex Pharmaceuticals’ Journavx, a new non-opioid pain pill for short-term pain. While safer than opioids, ...

Sequentially, revenue from operations grew by 2.9 per cent, whereas profit after tax (PAT) fell by 4.5 per cent ...

While Tapentadol is a serious habit-forming opioid-based drug, Pregabalin has become a headache in Punjab as it is ...

Patient monitors, used in both healthcare facilities and home settings, display vital patient information including ...

Robert F. Kennedy Jr. said he would hire a Native American to serve in his central office if confirmed as the nation's top ...

Dr. Mrinal M Gounder emphasizes the complexity of breast cancer and the necessity for unique treatments for its many variants ...

WASHINGTON: Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and ...

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and ...

VIENNA, Va., Jan. 30, 2025 (GLOBE NEWSWIRE) -- eHealth Exchange, one of the nation's largest health information networks, announces new board of directors. Four esteemed leaders will strengthen the ...

India's markets regulator on Friday extended the suspension in trading of derivative contracts of some grains and food items ...

Cotecna Life Sciences India Private Limited, formerly Geo-Chem Pharma, is proud to announce the inauguration of its new, ...

The pharma major's consolidated net profit increased 15.04% to Rs 2,903.38 crore on 10.46% rise in revenue from operations to Rs 13,675.46 crore in Q3 FY25 over Q3 FY24.